Eden Pharmaceutical Limited

1 October 2016 false No description of principal activity Taxfiler 2018.5.Web 04609974business:PrivateLimitedCompanyLtd2016-10-012017-09-30 046099742016-09-30 046099742016-10-012017-09-30 04609974business:AuditExemptWithAccountantsReport2016-10-012017-09-30 04609974business:FullAccounts2016-10-012017-09-30 046099742017-09-30 04609974business:Director12016-10-012017-09-30 04609974business:CompanySecretary12016-10-012017-09-30 04609974business:RegisteredOffice2016-10-012017-09-30 046099742016-09-30 04609974core:WithinOneYear2017-09-30 04609974core:WithinOneYear2016-09-30 04609974core:AfterOneYear2017-09-30 04609974core:AfterOneYear2016-09-30 04609974core:ShareCapital2017-09-30 04609974core:ShareCapital2016-09-30 04609974core:RetainedEarningsAccumulatedLosses2017-09-30 04609974core:RetainedEarningsAccumulatedLosses2016-09-30 04609974business:SmallEntities2016-10-012017-09-30 04609974countries:EnglandWales2016-10-012017-09-30 04609974core:AfterOneYear2016-10-012017-09-30 046099742015-10-012016-09-30 iso4217:GBP xbrli:pure
Company Registration No. 04609974 (England and Wales)
Eden Pharmaceutical Limited Unaudited accounts for the year ended 30 September 2017
Eden Pharmaceutical Limited Unaudited accounts Contents
Page
- 2 -
Eden Pharmaceutical Limited Company Information for the year ended 30 September 2017
Director
Nayan Thakrar
Secretary
Manisha Thakrar
Company Number
04609974 (England and Wales)
Registered Office
Unit 4 Stonefield Way Ruislip Middlesex HA4 0JW
Accountants
Cloud Audit and Accounts Ltd 1 Mill Street London SE1 2DE
- 3 -
Eden Pharmaceutical Limited Statement of financial position as at 30 September 2017
2017 
2016 
Notes
£ 
£ 
Fixed assets
Investment property
16,920,000 
20,170,000 
Current assets
Debtors
566,765 
842,713 
Cash at bank and in hand
350 
107 
567,115 
842,820 
Creditors: amounts falling due within one year
(2,948,735)
(2,991,931)
Net current liabilities
(2,381,620)
(2,149,111)
Total assets less current liabilities
14,538,380 
18,020,889 
Creditors: amounts falling due after more than one year
(6,729,688)
(8,482,447)
Provisions for liabilities
Deferred tax
- 
(490,763)
Net assets
7,808,692 
9,047,679 
Capital and reserves
Called up share capital
200 
200 
Profit and loss account
7,808,492 
9,047,479 
Shareholders' funds
7,808,692 
9,047,679 
For the year ending 30 September 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the Board on 29 June 2018.
Nayan Thakrar Director Company Registration No. 04609974
- 4 -
Eden Pharmaceutical Limited Notes to the Accounts for the year ended 30 September 2017
1
Statutory information
Eden Pharmaceutical Limited is a private company, limited by shares, registered in England and Wales, registration number 04609974. The registered office is Unit 4, Stonefield Way, Ruislip, Middlesex, HA4 0JW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Presentation currency
The accounts are presented in £ sterling.
Investment property
Investment property is included at market fair value. Gains are recognised in the income statement. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Turnover
Turnover, which excludes value added tax, comprises rental income which is recognised evenly over the term of the lease to which it relates.
4
Investment property
2017 
£ 
Fair value at 1 October 2016
20,170,000 
Net loss from fair value adjustments
(3,250,000)
At 30 September 2017
16,920,000 
The properties have been valued by independent external valuers in accordance with RICS Valuation - Global Standards 2017 under market value and market rent bases. The historic cost of the properties is £17,717,186.
5
Debtors
2017 
2016 
£ 
£ 
Other debtors
566,765 
842,713 
- 5 -
Eden Pharmaceutical Limited Notes to the Accounts for the year ended 30 September 2017
6
Creditors: amounts falling due within one year
2017 
2016 
£ 
£ 
Bank loans and overdrafts
1,752,750 
1,707,556 
Taxes and social security
718,390 
410,390 
Other creditors
472,417 
873,985 
Accruals
5,178 
- 
2,948,735 
2,991,931 
7
Creditors: amounts falling due after more than one year
2017 
2016 
£ 
£ 
Bank loans
6,076,779 
7,829,529 
Amounts owed to group undertakings and other participating interests
652,909 
652,918 
6,729,688 
8,482,447 
Bank borrowings are secured by way of a Debenture including fixed and floating charge over the assets and undertaking of the company and in addition there is a separate charge on a bank deposit.
8
Average number of employees
During the year the average number of employees was 0 (2016: 0).
- 6 -